Chemotherapy has been a conventional paradigm for cancer treatment, and multifarious
chemotherapeutic drugs have been widely employed for decades with significant …

Tumor immunotherapy, particularly the use of immune checkpoint inhibitors, has yielded
impressive clinical benefits. Therefore, it is critical to accurately screen individuals for …

Artificial intelligence (AI) and deep learning have emerged as powerful tools in
understanding the etiology and pathogenesis of cancers. These technologies help uncover …

Artificial intelligence (AI) indicates the application of machines to imitate intelligent behaviors
for solving complex tasks with minimal human intervention, including machine learning and …

The rapid development of artificial intelligence (AI) technologies in the context of the vast
amount of collectable data obtained from high-throughput sequencing has led to an …

Tumor neoantigen has a high degree of immunogenicity. As one of the emerging methods of
tumor immunotherapy, the vaccine developed against it has served to clinical trials of …

Although immune checkpoint inhibition has been shown to effectively activate antitumor
immunity in various tumor types, only a small subset of patients can benefit from PD-1/PD-L1 …

Artificial intelligence (AI) is a general term that refers to the use of a machine to imitate
intelligent behavior for performing complex tasks with minimal human intervention, such as …

Cancer immunotherapy can induce sustained responses in patients with cancers in a broad
range of tissues, however, these treatments require the optimized combined therapeutic …

Triple-negative breast cancer (TNBC) is heterogeneous cancer with poor prognosis among
the other breast tumors. Rapid recurrence and increased progression rate could be reasons …